HEPATIC ACETYLATOR PHENOTYPE IN DIABETIC POLYNEUROPATHY

被引:0
|
作者
QUESADA, JML
ROMERO, AA
OVIEDO, EC
PEREZ, MG
IGLESIAS, FC
CARCEDO, CF
GONZALEZ, EC
CREUS, PS
机构
来源
REVISTA CLINICA ESPANOLA | 1983年 / 168卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:399 / 402
页数:4
相关论文
共 50 条
  • [1] ACETYLATOR PHENOTYPE IN DIABETIC NEUROPATHY
    MCLAREN, EH
    BURDEN, AC
    MOORHEAD, PJ
    BRITISH MEDICAL JOURNAL, 1977, 2 (6082) : 291 - 293
  • [2] HEPATIC ACETYLATOR PHENOTYPE IN DIABETES-MELLITUS
    LADERO, JM
    ARROJO, A
    DESALAMANCA, RE
    GOMEZ, M
    CANO, F
    ALFONSO, M
    ANNALS OF CLINICAL RESEARCH, 1982, 14 (04): : 187 - 189
  • [3] INCIDENCE OF HEPATIC ALTERATIONS IN RELATION TO ISONIAZID ACETYLATOR PHENOTYPE
    PILHEU, JA
    DESALVO, MC
    MANCHINU, I
    DENEGRONI, NR
    SZEMZO, J
    MEDICINA-BUENOS AIRES, 1980, 40 (04) : 382 - 386
  • [4] HEPATIC ACETYLATOR PHENOTYPE IN BLADDER-CANCER PATIENTS
    LADERO, JM
    KWOK, CK
    JARA, C
    FERNANDEZ, L
    SILMI, AM
    TAPIA, D
    USON, AC
    ANNALS OF CLINICAL RESEARCH, 1985, 17 (03): : 96 - 99
  • [5] HEPATIC ACETYLATOR PHENOTYPE IN PORPHYRIA CUTANEA-TARDA
    LADERO, JM
    DESALAMANCA, RE
    CHINARRO, S
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1981, 270 (02) : 171 - 173
  • [6] ACETYLATOR PHENOTYPE IN PSORIASIS
    JIMENEZNIETO, LC
    LADERO, JM
    FERNANDEZGUNDIN, MJ
    ROBLEDO, A
    DERMATOLOGICA, 1989, 178 (03): : 136 - 137
  • [7] ENDRALAZINE AND ACETYLATOR PHENOTYPE
    MEEMS, L
    BOGERS, WAJL
    LANCET, 1983, 1 (8335) : 1220 - 1221
  • [8] AGING AND ACETYLATOR PHENOTYPE
    GACHALYI, B
    VAS, A
    KALDOR, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (03) : 377 - 377
  • [9] HEPATIC-FUNCTION IN RELATION TO ACETYLATOR PHENOTYPE IN CHILDREN TREATED WITH ANTITUBERCULAR DRUGS
    SETH, V
    BEOTRA, A
    INDIAN JOURNAL OF MEDICAL RESEARCH SECTION A-INFECTIOUS DISEASES, 1989, 89 : 306 - 309
  • [10] INHERITANCE OF ACETYLATOR PHENOTYPE IN MICE
    TANNEN, RH
    WEBER, WW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1980, 213 (03) : 480 - 484